BioCentury
ARTICLE | Company News

Aurora other research news

March 8, 1999 8:00 AM UTC

ABSC received a $100,000 Phase I SBIR grant from the National Cancer Institute to identify breast cancer gene targets and candidate compounds using its GenomeScreen technology. ...